|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Oncobiologics Inc.
| | | Phone: | (609) 619-3990 | Fax: | (609) 619-3980 | Year Established: | 2011 | Main Contact: | Stephen J. McAndrew, Ph.D., Senior VP, Business Development | | Other Contacts: | Stephen J. McAndrew, Ph.D., VP, Business Development Donald J. Griffith CPA, MBA, CFO Pankaj Mohan Ph.D., MBA, Founder & CEO Scott Gangloff, VP, Process Development and Manufacturing John K. Cini Ph.D., VP, Development Sciences
| | Company Description | Oncobiologics is a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. Its current focus is on technically challenging and commercially attractive mAbs in the disease areas of immunology and oncology. Oncobiologics is advancing its pipeline of eight biosimilar products, two of which are currently in clinical development. Led by a team of biopharmaceutical experts, Oncobiologics operates from in-house state-of-the-art fully integrated research and development, and manufacturing facility in Cranbury, New Jersey. Oncobiologics employs its BioSymphony™ Platform to address the challenges of biosimilar development and commercialization by developing high quality mAb biosimilars in an efficient and cost-effective manner on an accelerated timeline. | |
|
|
|
|
|